Manufacturing Equipment, Upstream Processing

Alentis Therapeutics to Advance Anti-Claudin-1 ADCs to Treat Solid Tumors on $181.4 Million Financing

November 19, 2024

Financing from OrbiMed, Novo Holdings, Jeito Capital, and others will enable Alentis Therapeutics to advance its pipeline of Claudin-1-targeted ADCs for treating solid tumors.

New Protein Production Platform

August 01, 2024

Syngene’s protein production platform uses a cell line and transposon-based technology licensed from Switzerland-based ExcellGene.

Univercells and University of Pennsylvania Expand Agreement for Gene Therapy Program

July 25, 2024

Univercells and the University of Pennsylvania are expanding their collaboration to evaluate certain bioreactors with the aim to scale up gene therapy manufacturing.

AGC Biologics Completes Denmark Expansion to Double Single-Use Bioreactor Capacity

June 12, 2024

The completed expansion at AGC Biologics'Copenhagen, Denmark, site, doubles the company's single-use bioreactor capacity for mammalian-based services.

Meeting Upstream Bioprocessing Challenges with Innovative Engineering Design (INTERPHEX 2024)

May 02, 2024

Global product manager at Cytiva, Eric Corti, discusses the challenges with designing a new single-use mixing system that ensures leak-free fluid handling operations at INTERPHEX 2024.

The Making of mRNA

April 26, 2024

A tidal wave of questions floats the need for more upstream automation.

A Look at New Airlift Technology in Single-Use Bioreactors Systems

December 11, 2023

Pharmaceutical Technology Europe® spoke with Fiona Bellot, sales director, Cellexus BioreactorSystems, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.

Sartorius and Repligen Launch Upstream Processing Intensification System

August 22, 2023

Sartorius’ Biostat STR now incorporates Repligen’s XCell ATF hardware.

Culture Biosciences and Cytiva to Collaborate on Innovative Upstream Bioprocessing

June 15, 2023

The bioreactor scaler tool helps scaling between development and manufacturing and to de-risk scaling activities and ensure product quality.

High-titre Vector Producing Cells

April 02, 2023

Decreasing vein to vein time saves lives.